Literature DB >> 7545320

Lymphocyte adhesion to human endothelial cells induces tissue factor expression via a juxtacrine pathway.

E Schmid1, T H Müller, R M Budzinski, K Pfizenmaier, K Binder.   

Abstract

To study the effect of lymphocyte adhesion on the procoagulant activity of endothelial cells, we have stimulated HUVECs with interferon-gamma to upregulate adhesion molecules. Subsequent addition of lymphocytes induced the expression of tissue factor (TF) by HUVECs. Both CD4+ and CD8+ T-cells promoted this TF synthesis via distinct adhesion molecules (CD4+ T-cells: E-selectin and ICAM-1; CD8+ T-cells: MHC-I molecules). In addition, tumor necrosis factor-alpha and -beta (TNF alpha, TNF beta) and platelet-activating factor (PAF) were involved in lymphocyte-mediated TF expression on HUVECs. We demonstrate that PAF plays a pivotal role in this process. Adhesion of lymphocytes to endothelial cell surface molecules induced the release of PAF. PAF, in turn, caused the production of TNF alpha and TNF beta, both of which are potent stimulators of TF expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545320

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

1.  Tumor necrosis factor induces tumor necrosis via tumor necrosis factor receptor type 1-expressing endothelial cells of the tumor vasculature.

Authors:  B Stoelcker; B Ruhland; T Hehlgans; H Bluethmann; T Luther; D N Männel
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Expressions of tissue factor and tissue factor pathway inhibitor in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Jinjin Hao; Weiming Li; Ping Zou; Quan Li; Linghui Xia; Yong You
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-12-29

3.  Modulation of neutrophil function by the tripeptide feG.

Authors:  Ronald D Mathison; A Dean Befus; Joseph S Davison; Richard C Woodman
Journal:  BMC Immunol       Date:  2003-03-04       Impact factor: 3.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.